| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Feb―26 |
Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study |
Nicole O’Dell, Amrit Baral, Marvin Reid, Bria-Necole A. Diggs, Jessica Y. Islam, Marlene Camacho-Rivera, Johis Ortega, Denise C. Vidot |
| 2 |
[GO] |
2024―Aug―28 |
Exploring the Relationship Between Cannabis Use And COVID-19 Outcomes |
Chapman Wei, Nawal Mustafa, Radu Grovu, Fasih Sami Siddiqui, Umesh K. Manchandani, Saud Bin Abdul Sattar, Waleed Sadiq, Ahmad Mustafa |
| 3 |
[GO] |
2023―Sep―15 |
Extracellular Vesicles and Endocannabinoid Signaling in Patients with COVID-19 |
Florian Brandes, Annekathrin M. Keiler, Benedikt Kirchner, Melanie Borrmann, Jean-Noël Billaud, Marlene Reithmair, Matthias Klein, Patrizia Campolongo, Detlef Thieme, Michael W. Pfaffl, Gustav Schelling, Agnes S. Meidert |
| 4 |
[GO] |
2022―Oct―17 |
A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome |
Thomas P. Young, Joel S. Erickson, Shannon L. Hattan, Serge Guzy, Fabienne Hershkowitz, Michael D. Steward |
| 5 |
[GO] |
2022―Jul―26 |
Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review |
Manuela Holst, Dennis Nowak, Eva Hoch |
| 6 |
[GO] |
2022―May―05 |
Cannabinoids as Emergent Therapy Against COVID-19 |
Joseph McGrail, Lucía Martín-Banderas, Matilde Durán-Lobato |
| 7 |
[GO] |
2022―Apr―01 |
Re: “Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” by Crippa et al. |
Luis Vitetta, Tomas Andersen, Michelle Quezada, Dave Rutolo, Jeremy D. Henson |
| 8 |
[GO] |
2022―Jan―28 |
Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey |
Mike Armour, Justin Sinclair, Junipearl Cheng, Preston Davis, Aaish Hameed, Harini Meegahapola, Krithika Rajashekar, Sunethra Suresh, Andrew Proudfoot, Mathew Leonardi |
| 9 |
[GO] |
2022―Jan―24 |
Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States |
Stephanie Lake, Ryan D. Assaf, Pamina M. Gorbach, Ziva D. Cooper |
| 10 |
[GO] |
2022―Jan―04 |
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic |
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, Francis Wong |
| 11 |
[GO] |
2021―Dec―17 |
Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment |
Aishwarya Saraswat, Richa Vartak, Manali Patki, Ketan Patel |
| 12 |
[GO] |
2021―Oct―09 |
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
José Alexandre S. Crippa, Julia Cozar Pacheco, Antonio W. Zuardi, Francisco S. Guimarães, Alline Cristina Campos, Flávia de Lima Osório, Sonia Regina Loureiro, Rafael G. dos Santos, José Diogo S. Souza, Juliana Mayumi Ushirohira, Rafael Rinaldi Ferreira, Karla Cristinne Mancini Costa, Davi Silveira Scomparin, Franciele Franco Scarante, Isabela Pires-Dos-Santos, Raphael Mechoulam, Flávio Kapczinski, Benedito A.L. Fonseca, Danillo L.A. Esposito, Afonso Dinis Costa Passos, Amaury Lelis Dal Fabbro, Fernando Bellissimo-Rodrigues, Eurico Arruda, Sandro Scarpelini, Maristela Haddad Andraus, Julio Cesar Nather Junior, Danilo Tadao Wada, Marcel Koenigkam-Santos, Antonio Carlos Santos, Geraldo Busatto Filho, Jaime E.C. Hallak |
| 13 |
[GO] |
2020―Nov―09 |
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? |
Saoirse E. O'Sullivan, Carl W. Stevenson, Steven R. Laviolette |
| 14 |
[GO] |
2020―Aug―28 |
Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs |
M. Hunter Land, Laura MacNair, Brian F. Thomas, Erica N. Peters, Marcel O. Bonn-Miller |
| 15 |
[GO] |
2020―Apr―28 |
Cannabinoids and the Coronavirus |
Kevin P. Hill |
|
